Evidence map›Paper›PMID 26104310›Full record

ArticleLipids in health and disease2015

Low density lipoprotein cholesterol control status among Canadians at risk for cardiovascular disease: findings from the Canadian Primary Care Sentinel Surveillance Network Database.

Erfan Aref-Eshghi, Jason Leung, Marshall Godwin, Pauline Duke, Tyler Williamson, Masoud Mahdavian, Shabnam Asghari

Abstract read
In one paragraph

Article in Lipids in health and disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erfan Aref-EshghiMemorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. erfanae@mun.ca.
Jason LeungMemorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. jl4125@mun.ca.
Marshall GodwinMemorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. godwinm@mun.ca.
Pauline DukeMemorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. pduke@mun.ca.
Tyler WilliamsonUniversity of Calgary, Calgary, Alberta, Canada. tyler.williamson@ucalgary.ca.
Masoud MahdavianUniversity of Ottawa, Ottawa, Ontario, Canada. Masoud.mahdavian@gmail.com.
Shabnam AsghariMemorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. shabnam.asghari@med.mun.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo determine the prevalence of uncontrolled LDL-C in patients with high cardiovascular disease (CVD) risks across Canada and to examine its related factors.

methodsNon-pregnant adults >20 years-old, who had a lipid test completed between January 1, 2009 and December 31, 2011 and were included in the Canadian Primary Care Surveillance Network (CPCSSN) database were studied. The Framingham-Risk-Score was calculated to determine the risk levels. A serum LDL-C level of >2.0 mmol/L was considered as being poorly controlled. Patients with a previous record of a cerebrovascular accident, peripheral artery disease, or an ischemic heart disease were regarded as those under secondary prevention. Logistic regression modeling was performed to examine the factors associated with the LDL-C control.

resultsA total of 6,405 high-risk patients were included in the study and, of this population, 68% had a suboptimal LDL-C, which was significantly associated with the female gender (OR: 3.26; 95% CI: 2.63-4.05, p < 0.0001) and no medication therapy (OR: 6.31, 95% CI: 5.21-7.65, p < 0.0001). Those with comorbidities of diabetes, hypertension, obesity, and smokers had a better LDL-C control. Rural residents (OR: 0.64, 95% CI: 0.52-0.78, p < 0.0001), and those under secondary prevention (OR: 0.42; 95 % CI: 0.35-0.51, p < 0.0001), were also more likely to have a better LDL-C control.

conclusionA high proportion of high-cardiac risk patients in Canadian primary care settings have suboptimal LDL-C control. A lack of medication therapy appears to be the major contributing factor to this situation.

Indexed as

Databases as TopicPrimary Health CareSentinel SurveillanceAdultAgedAged, 80 and overCanadaCardiovascular DiseasesCholesterol, LDLFemaleHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisPrevalenceCholesterol, LDL

Identifiers

PMID26104310
PMCPMC4485341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.